Lista de obras -

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens

artículo científico publicado en 2017

Abstract 953: Mechanistic rationale for inhibition of Poly(ADP-Ribose) Polymerase in ETS gene fusion positive prostate cancer

article

Accelerating precision medicine in metastatic prostate cancer

artículo científico publicado en 2020

An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer

artículo científico publicado en 2021

An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer

artículo científico publicado en 2021

Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer

artículo científico publicado en 2018

Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer

artículo científico

Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy

artículo científico publicado en 2017

CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer

artículo científico publicado en 2021

Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes

artículo científico publicado en 2015

Definition and Validation of "Favorable High-Risk Prostate Cancer": Implications for Personalizing Treatment of Radiation-Managed Patients

artículo científico publicado en 2015

Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis

artículo científico publicado en 2016

Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence

artículo científico publicado en 2022

Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancer.

artículo científico publicado en 2016

Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer

Gleason score 5 + 3 = 8 prostate cancer: much more like Gleason score 9?

artículo científico publicado en 2015

Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease

artículo científico publicado en 2017

Integrative clinical genomics of advanced prostate cancer

artículo científico publicado en 2015

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

artículo científico publicado en 2020

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.

artículo científico publicado en 2017

Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer

artículo científico publicado en 2011

MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2.

artículo científico publicado en 2016

National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate Cancer

artículo científico publicado en 2017

National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers?

artículo científico publicado en 2016

Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer

artículo científico publicado en 2015

PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer

artículo científico publicado en 2014

Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity

artículo científico publicado en 2020

Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states

artículo científico publicado en 2022

TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup

artículo científico publicado en 2017

Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1

artículo científico publicado en 2022

Targeting the MLL complex in castration-resistant prostate cancer

artículo científico publicado en 2015

The DNA methylation landscape of advanced prostate cancer

scientific article published on 13 July 2020

The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer

artículo científico publicado en 2015

The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair

artículo científico publicado en 2021

The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer

artículo científico publicado en 2014

The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer

artículo científico publicado en 2021

The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex

artículo científico publicado en 2013

Variation in National Use of Long-Term ADT by Disease Aggressiveness Among Men With Unfavorable-Risk Prostate Cancer

artículo científico publicado en 2016

Lista de obras de

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens

Abstract 953: Mechanistic rationale for inhibition of Poly(ADP-Ribose) Polymerase in ETS gene fusion positive prostate cancer

Accelerating precision medicine in metastatic prostate cancer

An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer

An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer

Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer

Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer

Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy

CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer

Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes

Definition and Validation of "Favorable High-Risk Prostate Cancer": Implications for Personalizing Treatment of Radiation-Managed Patients

Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis

Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence

Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancer.

Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer

Gleason score 5 + 3 = 8 prostate cancer: much more like Gleason score 9?

Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease

Integrative clinical genomics of advanced prostate cancer

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.

Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer

MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2.

National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate Cancer

National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers?

Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer

PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer

Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity

Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states

TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup

Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1

Targeting the MLL complex in castration-resistant prostate cancer

The DNA methylation landscape of advanced prostate cancer

The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer

The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair

The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer

The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer

The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex

Variation in National Use of Long-Term ADT by Disease Aggressiveness Among Men With Unfavorable-Risk Prostate Cancer